Ht6 - Do Spain and Portugal Evaluators and Decision Makers Give the Same Importance to Evaluation Criteria of Innovative Medicines?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Transition to Democracy in Spain and Portugal

American Political Science Review
SociologyInternational RelationsPolitical Science
1990English

Classifiers and Decision Makers

2004English

Pnd100 - Pricing of Innovative Medicines: Do Innovative Schemes Offer a Solution?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Trials and Clinical Practice: Do Doctors Use the Same Criteria to Judge Outcome?

British Journal of Clinical Pharmacology
Pharmacology
2003English

Surrogate Decision Makers and Acute Care

Anaesthesia
AnesthesiologyPain Medicine
2019English

To Give or Not to Give: Children’s and Adolescents’ Sharing and Moral Negotiations in Economic Decision Situations

Child Development
DevelopmentalChild HealthEducational PsychologyPerinatologySocial WorkPediatricsEducation
2008English

Identification of Important Criteria for Drug Reimbursement Decision-Making and Their Relative Importance

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pharmacogenomic Can Give Children Safer Medicines

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Human Capital and the Decision to Exploit Innovative Opportunity

Management Decision
AccountingManagementOperations ResearchBusinessManagement Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy